Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Malaysian Study On Hemodialysis Patients SARS-COV-2 Vaccination Immune Response: A Prospective Observational Cohort Study

NCT04872751 is registered in ClinicalTrials.gov with Penang Hospital, Malaysia as lead sponsor.

NCT NCT04872751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04872751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Malaysian Study On Hemodialysis Patients SARS-COV-2 Vaccination Immune Response: A Prospective Observational Cohort Study
Lead sponsor
Penang Hospital, Malaysia
Phase
Observational
Overall status
Unknown status
Start date
April 27, 2021
Completion date
April 30, 2022
Enrollment
425 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune response post covid 19 vaccination